Crossmark

CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid—a promising combination strategy for therapeutic intervention

Crossref DOI link: https://doi.org/10.1038/s41420-025-02637-z

Published Online: 2025-08-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shokraie, Fatemeh

Lechermeier, Larissa

Bordihn, Pia

Kaps, Philipp

Möller, Steffen

Schulz, Anna Sophie

Schneider, Björn https://orcid.org/0000-0002-0282-7330
Koczan, Dirk

Roshan, Samira Khanipour

Lode, Holger N.

Classen, Carl-Friedrich

Hahn, Olga

Troschke-Meurer, Sascha

Maletzki, Claudia https://orcid.org/0000-0002-8389-8439
License Information

Text and Data Mining valid from 2025-08-02

Version of Record valid from 2025-08-02
More Information

Article History

Received: 13 February 2025

Revised: 2 June 2025

Accepted: 9 July 2025

First Online: 2 August 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below